Giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to a trial we funded.
The UK government is almost a decade behind achieving its target for England to be smokefree by 2030, a new report reveals.
A landmark report on deprivation and cancer launched at the Scottish Cancer Conference today shows that the burden of cancer is not felt equally across Scotland.
Cancer Research UK, in partnership with tech company Stitch, are going live with an app for patients to use whilst participating in a clinical trial.
The “potentially life-saving” immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales.
Today, we’ve announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx.
The National Institute for Health and Care Excellence (NICE) has recommended zanubrutinib (Brukinsa) as an option for treating some people…
It’s known that people from more deprived backgrounds are more likely to get cancer. New analysis from Cancer Research UK…
NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective